Trade

with

Merck & Co Inc
(NYSE: MRK)
AdChoices
54.05
+0.03
+0.06%
After Hours :
54.06
+0.01
+0.02%

Open

54.22

Previous Close

54.02

Volume (Avg)

12.06M (9.25M)

Day's Range

53.92-54.27

52Wk Range

44.62-61.33

Market Cap.

155.91B

Dividend Rate (Yield )

1.76 (3.26%)

Beta

0.43

Shares Outstanding

2.88B

P/E Ratio (EPS)

28.49 (1.90)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 44.03B

    • Net Income

    • 4.40B

    • Market Cap.

    • 155.91B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 12.89

    • PEG (Price/Earnings Growth) Ratio

    • 4.51

    • Beta

    • 0.43

    • Forward P/E

    • 15.06

    • Price/Sales

    • 3.67

    • Price/Book Value

    • 3.22

    • Price/Cash flow

    • 14.90

      • EBITDA

      • 13.33B

      • Return on Capital %

      • 5.48

      • Return on Equity %

      • 11.71

      • Return on Assets %

      • 5.48

      • Book Value/Share

      • 16.76

      • Shares Outstanding

      • 2.88B

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.44 (9/11/2014)

      • Dividend Declaration Date

      • 7/23/2014

      Analyst Recommendation
      10/17/2014
      Outperform
        • 1 Year Price Target

        • 64.00

        • Credit Rating

        • AA

        • Analysts

        • 5

        • EPS Estimate

        • 2.97

        • Cashflow Estimate

        • 4.84

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -0.70

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -28.60

          • 7.80

          • Net Income

            Q/Q (last year)

          • 121.20

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • 13.05

          • 6.10

          • Net Income

            5-Year Annual Average

          • -10.80

          • 3.73

          • Dividends

            5-Year Annual Average

          • 2.62

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 59.80

            • 69.92

            • Pre-Tax Margin

            • 15.46

            • 21.84

            • Net Profit Margin

            • 12.89

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 63.70

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 21.10

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • 17.00

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.38

              • 0.32

              • Current Ratio

              • 1.87

              • 1.92

              • Quick Ratio

              • 1.14

              • 1.31

              • Interest Coverage

              • 9.50

              • 17.64

              • Leverage Ratio

              • 2.02

              • 2.03

              • Book Value/Share

              • 16.76

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 30.96

                • 21.74

                • P/E Ratio 5-Year High

                • 32.33

                • 193.96

                • P/E Ratio 5-Year Low

                • 15.54

                • 87.26

                • Price/Sales Ratio

                • 3.99

                • 3.68

                • Price/Book Value

                • 3.50

                • 3.66

                • Price/Cash Flow Ratio

                • 14.90

                • 13.76

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 11.71

                    (13.20)

                  • 17.42

                    (18.66)

                  • Return on Assets %

                    (5-Year Average)

                  • 5.48

                    (6.60)

                  • 8.45

                    (8.77)

                  • Return on Capital %

                    (5-Year Average)

                  • 8.55

                    (10.70)

                  • 12.41

                    (13.18)

                  • Income/Employee

                  • 73.87k

                  • 90.07k

                  • Inventory Turnover

                  • 2.71

                  • 2.46

                  • Asset Turnover

                  • 0.43

                  • 0.46

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  6.36B
                  Operating Margin
                  14.44
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  14.90
                  Ownership

                  Institutional Ownership

                  76.89%

                  Top 10 Institutions

                  30.43%

                  Mutual Fund Ownership

                  42.48%

                  Float

                  99.97%

                  5% / Insider Ownership

                  0.07%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • VA CollegeAmerica Income Fund of America

                  •  

                    50,113,640

                  • 0.85

                  • 1.74

                  • VA CollegeAmerica Washington Mutual

                  •  

                    48,141,400

                  • 2.98

                  • 1.67

                  • Vanguard Total Stock Mkt Idx

                  •  

                    47,470,515

                  • 0.02

                  • 1.65

                  • Vanguard Health Care Fund

                  •  

                    33,889,948

                  • -4.85

                  • 1.17

                  • Vanguard Five Hundred Index Fund

                  •  

                    29,947,408

                  • -1.06

                  • 1.04

                  • Vanguard Institutional Index Fund

                  •  

                    29,224,632

                  • -2.33

                  • 1.01

                  • SPDR® S&P 500 ETF

                  •  

                    28,748,295

                  • -1.09

                  • 0.91

                  • Vanguard Wellington™

                  •  

                    27,713,952

                  • 0.00

                  • 0.96

                  • VA CollegeAmerica American Balanced

                  •  

                    25,315,000

                  • -1.61

                  • 0.88

                  • VA CollegeAmerica Fundamental Investors

                  •  

                    22,285,000

                  • 0.00

                  • 0.77

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Capital World Investors

                  •  

                    174,926,284

                  • +0.82%

                  • 6.03

                  • Wellington Management Company, LLP

                  •  

                    152,491,759

                  • -2.92%

                  • 5.26

                  • Vanguard Group, Inc.

                  •  

                    150,630,864

                  • +1.79%

                  • 5.19

                  • State Street Corp

                  •  

                    124,323,638

                  • -3.17%

                  • 4.29

                  • BlackRock Fund Advisors

                  •  

                    89,275,723

                  • -2.17%

                  • 3.08

                  • T. Rowe Price Associates, Inc.

                  •  

                    45,526,605

                  • +0.81%

                  • 1.57

                  • Northern Trust Investments, N.A.

                  •  

                    43,810,714

                  • +0.19%

                  • 1.51

                  • Fidelity Management and Research Company

                  •  

                    42,815,731

                  • -20.28%

                  • 1.48

                  • Dodge & Cox

                  •  

                    35,960,137

                  • -10.01%

                  • 1.24

                  • Government Pension Fund of Norway - Global

                  •  

                    34,730,520

                  • -27.06%

                  • 0.78

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Major

                  Type

                  Slow Growth

                  Style

                  Large Value

                  Merck & Co Inc was incorporated in New Jersey in 1970. The Company is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, w...morehich it markets directly and through its joint ventures. The Company’s operations are mainly managed on a products basis and are comprised of four operating segments, which are the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment, which is the Pharmaceutical segment. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescript...moreion, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company sells these human health vaccines primarily to physicians, wholesalers, physician distributors and government entities. The Company also has animal health operations that discover, develop, manufacture and market animal health products, including vaccines, which the Company sells to veterinarians, distributors and animal producers. Additionally, the Company has consumer care operations that develop, manufacture and market over-the-counter, foot care and sun care products, which are sold through wholesale and retail drug, food chain and mass merchandiser outlets, as well as club stores and specialty channels. The Company’s competitors include other worldwide research-based pharmaceutical companies, smaller research companies with more limited therapeutic focus, and generic drug and consumer health care manufacturers. The Company’s activities, including research, preclinical testing, clinical trials and manufacturing and marketing its products, are subject to regulation by numerous federal, state and local governmental authorities in the United States, including the FDA, and by foreign regulatory authorities, including the European Commission.lessless

                  Key People

                  Kenneth C. Frazier

                  CEO/Chairman of the Board/Director/President

                  Robert M. Davis

                  Executive VP/CFO

                  Clark Golestani

                  Chief Information Officer/Executive VP

                  Bruce N. Kuhlik

                  Executive VP/General Counsel

                  Richard R. DeLuca,Jr

                  Executive VP/President, Divisional

                  • Merck & Co Inc

                  • One Merck Drive

                  • Whitehouse Station, NJ 08889-0100

                  • USA.Map

                  • Phone: +1 908 423-1000

                  • Fax: +1 908 735-1253

                  • merck.com

                  Incorporated

                  1970

                  Employees

                  76,000

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: